Xinfeng Chen

机构：Nantong University, Affiliated Hospital of Nantong University, Henan Cancer Hospital, First Affiliated Hospital of Zhengzhou University, Jiangxi Agricultural University · ORCID：0000-0001-6992-1957

发表论文 206 篇 · 总被引 5188 次 · h-index 39

代表论文

• In vivo CAR-T cell therapy: New breakthroughs for cell-based tumor immunotherapy (2025 · Human Vaccines & Immunotherapeutics · 被引 15)
• Navigating the frontier of CAR-T cell resistance: From underlying mechanisms to innovative therapeutic solutions (2026 · Molecular Immunology · 被引 2)
• Potential of Urinary Mutation and Methylation Biomarkers in Selecting Candidates for Repeat Transurethral Resection of Bladder Tumor in Non–muscle-invasive Bladder Cancer: A Prospective Multicenter Study (2025 · European Urology Open Science · 被引 2)
• H2AFY2 suppresses exhaustion and enhances antitumor activity of CAR-T cells through transcriptional and epigenetic modifications (2026 · Cancer Immunology Research)
• Dietary 4-Hydroxy-2,5-Dimethyl-3(2H)-Furanone Supplementation in Hu Sheep: Implications on Fecal and Rumen Microbiota (2026 · Animals)
• Table S1 from Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1<sup>+</sup> T-Cell Therapy in Patients with Solid Tumors (2026)